<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02092740</url>
  </required_header>
  <id_info>
    <org_study_id>DE-UKMD-URO-0023</org_study_id>
    <nct_id>NCT02092740</nct_id>
  </id_info>
  <brief_title>REtrospective Study of TESTIcular CAncer Patients at the University Magdeburg</brief_title>
  <acronym>RETESTICAPUM</acronym>
  <official_title>Retrospective Analysis of Testicular Cancer Patients With Histopathological Analysis or Urological Treatment at the University Magdeburg 1960-2012.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Magdeburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Magdeburg</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective analysis of treatment outcome and side effects of testicular cancer patients
      that had been diagnosed at the University Magdeburg from 1960 until 2012.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Creating an ACCESS Windows form based Data Registry for testicular cancer patients.

      Relevant data for testicular cancer patients based on EAU-guidelines 2013 and EORTC/RTOG,
      Lent-SOMA, CTC. All testicular cancer patients who had been histopathologically diagnosed al
      the Institute of Pathology at the University Magdeburg. About 2000 patients from 1960 until
      2012. Postgraduate students collecting data requesting hospital documents, cancer registry of
      Sachsen-Anhalt, family practitioners and urologists as well as patients. Statistically
      Analysis with ACCESS and IBM SPSS statistics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival (OS)</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>Overall survival (OS).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-specific survival.</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>Disease-specific survival of testicular cancer.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic side effects of testicular-cancer-specific radiation therapies.</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>All Therapy Associated side effects of radiation therapy using EORTC (European Organisation for Research and Treatment of Cancer) /RTOG- (Radiation Therapy Oncology Group) - RTOG/EORTC Late Radiation Morbidity Scoring Schema), LENT-SOMA-(Late Effects of Normal Tissues)-, CTCAE-(Common Terminology Criteria for Adverse Events V4)-Scores. See</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic side effects of testicular-cancer-specific chemotherapies.</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>All Therapy Associated side effects of chemotherapy using CTCAE-(Common Terminology Criteria for Adverse Events V4)-Score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic side effects of testicular-cancer-specific surgical therapies.</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>All Therapy Associated side effects of surgical therapy using CTCAE-(Common Terminology Criteria for Adverse Events V4)-Score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Malignoma</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>Assessment of Development of Secondary malignoma after diagnosis of testicular cancer; Secondary malignoma other than testicular cancer and metachronous Primary testicular cancer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progressive-free survival (PFS).</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>Progressive-free survival (PFS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relapse-free survival (RLS).</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>Relapse-free survival (RLS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL).</measure>
    <time_frame>Current situation.</time_frame>
    <description>Assessment of the current QoL using ECOG and EORTC-QLQ-C30-V3D.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cause of death.</measure>
    <time_frame>Up to 52 years.</time_frame>
    <description>Cause of death.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">2000</enrollment>
  <condition>Testicular Cancer</condition>
  <arm_group>
    <arm_group_label>Seminoma</arm_group_label>
    <description>Seminoma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Seminoma</arm_group_label>
    <description>Non-Seminoma</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Testicular cancer histopathologically diagnosed at the University Magdeburg 1960-2012
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  testicular cancer histopathologically diagnosed at the University Magdeburg Germany

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Johann J Wendler, Dr. Med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Urology University Magdeburg Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Urology University Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <state>Sachsen-Anhalt</state>
        <zip>39120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2014</study_first_submitted>
  <study_first_submitted_qc>March 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2014</study_first_posted>
  <last_update_submitted>March 20, 2014</last_update_submitted>
  <last_update_submitted_qc>March 20, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Magdeburg</investigator_affiliation>
    <investigator_full_name>Johann J. Wendler, MD</investigator_full_name>
    <investigator_title>Dr. med. Johann Jakob Wendler</investigator_title>
  </responsible_party>
  <keyword>Testicular cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testicular Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

